IDH1-mutated intrahepatic cholangiocarcinomas (IDH1m iCCAs) could be treated with anti-IDH1 drugs, although the high heterogeneity in this class of tumours could limit treatment efficacy.
Next-generation sequencing analysis of cholangiocarcinoma identifies distinct IDH1-mutated clusters
Loi, EleonoraCo-primo
;Scartozzi, Mario;Lai, Eleonora;Pretta, Andrea;Cascinu, Stefano;Patrizia, ZavattariPenultimo
;Casadei-Gardini, Andrea
2022-01-01
Abstract
IDH1-mutated intrahepatic cholangiocarcinomas (IDH1m iCCAs) could be treated with anti-IDH1 drugs, although the high heterogeneity in this class of tumours could limit treatment efficacy.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
2022EuropeanJournalOfCancerRimini.pdf
Solo gestori archivio
Descrizione: Full text
Tipologia:
versione editoriale
Dimensione
1.2 MB
Formato
Adobe PDF
|
1.2 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
